De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma
Diana D. Shi(Harvard University), William G. Kaelin(Broad Institute), Bofu Huang(Brigham and Women's Hospital), Joseph Buehler(Children's Medical Center), Keith L. Ligon(Brigham and Women's Hospital), Ralph J. DeBerardinis(Children's Medical Center), Daniel P. Cahill(Harvard University), J Lee(Brigham and Women's Hospital), Yu‐Fen Lin(Emory University), Peter Ly(The University of Texas Southwestern Medical Center), Misty S. Martin-Sandoval(Children's Medical Center), Julie-Aurore Losman(Brigham and Women's Hospital), Milan R. Savani(Children's Medical Center), Michael M. Levitt(University of North Texas), Thomas P. Mathews(Children's Medical Center), Vinesh T. Puliyappadamba(Children's Medical Center), John M. Asara(Beth Israel Deaconess Medical Center), Lin Xu(Southwestern Medical Center), Sabina Signoretti(Brigham and Women's Hospital), Nathalie Y.R. Agar(Texas Endosurgery Institute), Amy Cameron(Dana-Farber Cancer Institute), Lei Guo(Wenzhou Medical University), Jennifer E. Endress(Harvard University), Lauren C. Gattie(Children's Medical Center), Mark A. Lehrman(The University of Texas Southwestern Medical Center), Rebecca B. Jennings(IHS Markit (United States)), Sylwia A. Stopka(Brigham and Women's Hospital), Harley I. Kornblum(Neurobehavioral Systems), Timothy E. Richardson(Indiana University – Purdue University Indianapolis), Lauren G. Zacharias(Children's Medical Center), Adam C. Wang(Brigham and Women's Hospital), Isaac S. Harris(University of Rochester Medical Center), Laura Evans(Bayer (United States)), Andreas Sutter(Bayer (Germany)), Min Xu(Shanghai Institutes for Biological Sciences), Quang‐Dé Nguyen(Dana-Farber Cancer Institute), Michael S. Regan(Brigham and Women's Hospital), Ryan Looper(University of Utah), Januka Khanal(Brigham and Women's Hospital), Dennis M. Bonal(Dana-Farber Cancer Institute), Cylaina Bird(Neurological Surgery), Andreas Janzer(Bayer (Germany)), Kalil G. Abdullah(University of Pittsburgh), Tammie Dang(The University of Texas Southwestern Medical Center), Yi Xiao(The University of Texas Southwestern Medical Center), Sung-Woo Lee(Daegu-Gyeongbuk Medical Innovation Foundation), Wenhua Gao(Brigham and Women's Hospital), Tak W. Mak(University Health Network), Michael Jeffers(Sepragen Corporation (United States)), Stefan Gradl(Bayer (Germany))
Cited by 132
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O <sub>2</sub> Sensing
|Science|2001|4.7k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k